Journal
/
/
Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
Determination of Chemical Inhibitor Efficiency against Intracellular Toxoplasma Gondii Growth Using a Luciferase-Based Growth Assay
DOI:

09:49 min

April 29, 2020

, , , , ,

Chapters

  • 00:04Introduction
  • 00:49Luciferase-Based ToxoplasmaGrowth Assay
  • 02:25Chemical Compound Inhibition Efficacy Evaluation
  • 04:08CRISPR-Cas9-Based Gene Deletion
  • 05:59Toxoplasma Transfection
  • 06:51Knockout Parasite Cloning
  • 08:06Results: Representative LHVS Inhibition Efficacy Against Intracellular Toxoplasma Growth
  • 09:22Conclusion

Summary

Automatic Translation

Presented here is a protocol to evaluate the inhibition efficacy of chemical compounds against in vitro intracellular growth of Toxoplasma gondii using a luciferase-based growth assay. The technique is used to confirm inhibition specificity by genetic deletion of the corresponding target gene. The inhibition of LHVS against TgCPL protease is evaluated as an example.

Related Videos

Read Article